“…The copyright holder for this preprint (which was not this version posted March 27, 2019. ; https://doi.org/10.1101/590216 doi: bioRxiv preprint TPBG was first identified in trophoblasts (Hole & Stern, 1988) and has been mainly studied in embryonic development and in cancer (Barrow, Ward, Rutter, Ali, & Stern, 2005), where it is required for cell surface expression of CXCR4, a G-protein coupled receptor that mediates a chemotactic response to the CXCL12 chemokine (McGinn, Marinov, Sawan, & Stern, 2012;Southgate et al, 2010), and where it is diagnostic for metastasis and poor prognosis in cancer patients (Pukrop & Binder, 2008;Weeraratna et al, 2002). In mammalian embryonic cell lines, TPBG influences cytoskeletal organization and cell motility through modulation of Wnt signaling (Kagermeier-Schenk et al, 2011), and has also shown to bind to the PDZ domain of GIPC1, a scaffolding protein that regulates cell surface expression of G protein-coupled receptors (Awan et al, 2002).…”